Isomorphic Labs Advances AI-Designed Cancer Drug Toward Human Trials
Apr 26, 2026
Isomorphic Labs said one AI-designed drug, ISM8969, has FDA clearance for human clinical trials. The company’s initial pipeline focuses on oncology candidates.
News Related to Google DeepMind
Related coverage linked through entity extraction aliases.
AI-Driven Precision Medicine Market to Reach $9.7 Billion by 2035
Mar 24, 2026
The AI-driven precision medicine market is projected to grow from $0.7 billion in 2025 to $9.7 billion by 2035 at a 26.8% CAGR. North America dominates with 62-67% market share, while machine learning accounts for 39% of the market. The market is moderately consolidated with the top five players controlling over 64% share.
Isomorphic Labs Unveils Proprietary AI Drug Discovery Model IsoDDE
Feb 28, 2026
Isomorphic Labs released a 27-page technical report on IsoDDE, its new AI drug-discovery engine that outperforms existing models in predicting drug-protein interactions and antibody structures, but the proprietary system offers limited technical details.
AI Transforms Drug Discovery Amid Legal Uncertainty Over Patent Rights and Profit Sharing
Feb 13, 2026
Artificial intelligence is accelerating drug discovery from molecule screening to clinical trials, but legal uncertainty over patent ownership and profit distribution threatens to slow progress as the technology reshapes pharmaceutical development.
Google DeepMind Unveils IsoDDE Drug Discovery Engine, Updates Gemini Deep Think
Feb 13, 2026
Isomorphic Labs introduced IsoDDE, a drug discovery engine that outperforms AlphaFold 3 by a factor of two in prediction accuracy. Google also updated Gemini 3 Deep Think, which now outperforms competing models in complex scientific tasks.